반응식
[CH2:1]([C:5]1[S:9][C:8]([NH2:10])=[N:7][C:6]=1[CH3:11])[CH2:2][CH2:3][CH3:4].[Cl:12][C:13]1[CH:18]=[C:17]([Cl:19])[CH:16]=[C:15]([CH3:20])[C:14]=1[S:21](Cl)(=[O:23])=[O:22]>>[CH2:1]([C:5]1[S:9][C:8]([NH:10][S:21]([C:14]2[C:15]([CH3:20])=[CH:16][C:17]([Cl:19])=[CH:18][C:13]=2[Cl:12])(=[O:23])=[O:22])=[N:7][C:6]=1[CH3:11])[CH2:2][CH2:3][CH3:4]참가 물질
3
실험 절차
The title compound was prepared from 5-butyl-4-methyl-1,3-thiazol-2-ylamine (METHOD I) and 2,4-dichloro-6-methylbenzenesulfonyl chloride as described in the synthetic METHOD B to give a yellow solid (41 mg) with purity >90%. MS (pos) m/z 393.2, 395.2.
출처 및 근거
- ORD 기록
- ord-c8a6d497adbf467d8de04187023a9f81
- 출처 데이터셋
- uspto-grants-2006_10
- 특허 번호
- US07125900B2
연결된 노트
불러오는 중…